Cargando…
Tumor suppressive functions of LZTFL1 in hepatocellular carcinoma
Background: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality worldwide. The poor survival may be due to tumor recurrence and metastasis. Growing evidence indicates that Leucine Zipper Transcription Factor-like 1 (LZTFL1) plays an important role in tumor progressi...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628092/ https://www.ncbi.nlm.nih.gov/pubmed/31371991 http://dx.doi.org/10.2147/OTT.S196925 |
_version_ | 1783434885540610048 |
---|---|
author | Li, Shasha Li, Jingjing Yu, Zujiang |
author_facet | Li, Shasha Li, Jingjing Yu, Zujiang |
author_sort | Li, Shasha |
collection | PubMed |
description | Background: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality worldwide. The poor survival may be due to tumor recurrence and metastasis. Growing evidence indicates that Leucine Zipper Transcription Factor-like 1 (LZTFL1) plays an important role in tumor progression of several cancers such as lung cancer and gastric cancer. Methods: Real-time PCR was performed to evaluate LZTFL1 expression level in HCC cell lines and patient specimens. The relationship between LZTFL1 expression and the clinicopathological data of the patients was analyzed. Stable cell lines with overexpressing LZTFL1 were set-up, and the cell proliferation, migration, and invasion abilities were analyzed. The protein expression was measured by Western blotting. Results: Here, we found LZTFL1 expression was decreased in human HCC specimens and HCC cell lines. Downregulation of LZTFL1 expression was correlated with tumor stage and metastasis. The ectopic overexpression of LZTFL1 inhibited cell proliferation, migration, invasion, and the expression of MMP9. In addition, LZTFL1 suppressed epithelial mesenchymal transition (EMT). Conclusion: Taken together, our results highlight the tumor suppressive role of LZTFL1 in HCC, suggesting that LZTFL1 may represent a potential therapeutic strategy for treating patients with HCC. |
format | Online Article Text |
id | pubmed-6628092 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Dove |
record_format | MEDLINE/PubMed |
spelling | pubmed-66280922019-08-01 Tumor suppressive functions of LZTFL1 in hepatocellular carcinoma Li, Shasha Li, Jingjing Yu, Zujiang Onco Targets Ther Original Research Background: Hepatocellular carcinoma (HCC) is the third leading cause of cancer-related mortality worldwide. The poor survival may be due to tumor recurrence and metastasis. Growing evidence indicates that Leucine Zipper Transcription Factor-like 1 (LZTFL1) plays an important role in tumor progression of several cancers such as lung cancer and gastric cancer. Methods: Real-time PCR was performed to evaluate LZTFL1 expression level in HCC cell lines and patient specimens. The relationship between LZTFL1 expression and the clinicopathological data of the patients was analyzed. Stable cell lines with overexpressing LZTFL1 were set-up, and the cell proliferation, migration, and invasion abilities were analyzed. The protein expression was measured by Western blotting. Results: Here, we found LZTFL1 expression was decreased in human HCC specimens and HCC cell lines. Downregulation of LZTFL1 expression was correlated with tumor stage and metastasis. The ectopic overexpression of LZTFL1 inhibited cell proliferation, migration, invasion, and the expression of MMP9. In addition, LZTFL1 suppressed epithelial mesenchymal transition (EMT). Conclusion: Taken together, our results highlight the tumor suppressive role of LZTFL1 in HCC, suggesting that LZTFL1 may represent a potential therapeutic strategy for treating patients with HCC. Dove 2019-07-10 /pmc/articles/PMC6628092/ /pubmed/31371991 http://dx.doi.org/10.2147/OTT.S196925 Text en © 2019 Li et al. http://creativecommons.org/licenses/by-nc/3.0/ This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution – Non Commercial (unported, v3.0) License (http://creativecommons.org/licenses/by-nc/3.0/). By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms (https://www.dovepress.com/terms.php). |
spellingShingle | Original Research Li, Shasha Li, Jingjing Yu, Zujiang Tumor suppressive functions of LZTFL1 in hepatocellular carcinoma |
title | Tumor suppressive functions of LZTFL1 in hepatocellular carcinoma |
title_full | Tumor suppressive functions of LZTFL1 in hepatocellular carcinoma |
title_fullStr | Tumor suppressive functions of LZTFL1 in hepatocellular carcinoma |
title_full_unstemmed | Tumor suppressive functions of LZTFL1 in hepatocellular carcinoma |
title_short | Tumor suppressive functions of LZTFL1 in hepatocellular carcinoma |
title_sort | tumor suppressive functions of lztfl1 in hepatocellular carcinoma |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6628092/ https://www.ncbi.nlm.nih.gov/pubmed/31371991 http://dx.doi.org/10.2147/OTT.S196925 |
work_keys_str_mv | AT lishasha tumorsuppressivefunctionsoflztfl1inhepatocellularcarcinoma AT lijingjing tumorsuppressivefunctionsoflztfl1inhepatocellularcarcinoma AT yuzujiang tumorsuppressivefunctionsoflztfl1inhepatocellularcarcinoma |